Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

11 Dec 2015 07:00

RNS Number : 7616I
MJ Gleeson PLC
11 December 2015
 

MJ Gleeson PLC

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of M J Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in London, the Chairman, Dermot Gleeson, will state:

"Gleeson Homes has performed strongly in the five months to November 2015, during which it has completed 314 sales (compared with 259 sales in the equivalent period last year). The Government's Help to Buy scheme remained popular during the period, with 53% of customers taking advantage of it. Our own bespoke purchaser assistance packages also continued to be attractive.

"The division currently has 44 active sites, compared with 39 at this time last year. A significant number of sites are due to open and management expects the number of active sites to be approaching 50 by June 2016.

"Gleeson Homes currently has a land pipeline of 7,717 plots, of which 4,003 are owned and 3,714 are conditionally purchased, along with a further 961 plots actively being considered.

"The outlook for the division continues to be very encouraging, with strong customer demand in all regions, supported by improved mortgage availability. We are encouraged by the Halifax Building Society's announcement that it will increase its maximum financial exposure to housebuilders' individual development sites from 30% to 50% of total value and we welcome the announcement of further measures to encourage house building in the Autumn Statement.

"Against this very positive background, the Board expects Gleeson Homes to record an increase in completions for the year to 30 June 2016 of not less 15% compared with the prior year total of 751 units.

"In the first five months of the current financial year, Gleeson Strategic Land has performed significantly ahead of the corresponding period last year, selling two sites with planning permission for a combined total of 405 residential units and a site with consent for commercial use on 112.7 thousand square metres.

"The division's land pipeline currently consists of 68 sites, totalling 3,905 gross acres, which have the potential to deliver approximately 21,250 units. The portfolio includes eight sites with either planning permission or a resolution to grant planning permission. Six of these, which will deliver 632 units, are being progressed for sale in the current financial year.

"There are also 20 sites where the division is currently awaiting either the determination of a planning application or the outcome of a planning appeal.

"The Board expects the results, for the Group as a whole, for the first six months to December 2015 to show a strong increase on the first half of the prior financial half year. Based on the current level of trading in Gleeson Homes and the potential for further sales by Gleeson Strategic Land in the second half of the financial year, the Board now believes that results for the full year to 30 June 2016 will exceed expectations."

 

11 December 2015

 

Enquiries:

MJ Gleeson plc

 Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFMMMZVMLGKZG
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.